BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20602725)

  • 1. Plasma BDNF and tPA are associated with late-onset geriatric depression.
    Shi Y; You J; Yuan Y; Zhang X; Li H; Hou G
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):249-54. PubMed ID: 20602725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.
    Jiang H; Chen S; Li C; Lu N; Yue Y; Yin Y; Zhang Y; Zhi X; Zhang D; Yuan Y
    Transl Psychiatry; 2017 Apr; 7(4):e1079. PubMed ID: 28375203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum BDNF levels before treatment predict SSRI response in depression.
    Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment.
    Sagud M; Nikolac Perkovic M; Vuksan-Cusa B; Maravic A; Svob Strac D; Mihaljevic Peles A; Zivkovic M; Kusevic Z; Pivac N
    Psychopharmacology (Berl); 2016 Sep; 233(17):3259-67. PubMed ID: 27356518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
    Ristevska-Dimitrovska G; Shishkov R; Gerazova VP; Vujovik V; Stefanovski B; Novotni A; Marinov P; Filov I
    Psychiatr Danub; 2013 Jun; 25(2):123-7. PubMed ID: 23793275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients.
    Ricci V; Pomponi M; Martinotti G; Bentivoglio A; Loria G; Bernardini S; Caltagirone C; Bria P; Angelucci F
    J Clin Psychopharmacol; 2010 Dec; 30(6):751-3. PubMed ID: 21057246
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression.
    Tsai SJ
    Med Hypotheses; 2007; 68(6):1296-9. PubMed ID: 17097821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters.
    Skibinska M; Kapelski P; Rajewska-Rager A; Pawlak J; Szczepankiewicz A; Narozna B; Twarowska-Hauser J; Dmitrzak-Weglarz M
    Nord J Psychiatry; 2018 Apr; 72(3):191-196. PubMed ID: 29235396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study.
    Sheldrick A; Camara S; Ilieva M; Riederer P; Michel TM
    Eur Psychiatry; 2017 Oct; 46():65-71. PubMed ID: 29102768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.
    Martocchia A; Curto M; Scaccianoce S; Comite F; Xenos D; Nasca C; Falaschi GM; Ferracuti S; Girardi P; Nicoletti F; Falaschi P
    Aging Clin Exp Res; 2014 Aug; 26(4):461-4. PubMed ID: 24435333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.
    Lee HY; Kim YK
    Neuropsychobiology; 2008; 57(4):194-9. PubMed ID: 18679038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.
    Molendijk ML; Bus BA; Spinhoven P; Penninx BW; Kenis G; Prickaerts J; Voshaar RC; Elzinga BM
    Mol Psychiatry; 2011 Nov; 16(11):1088-95. PubMed ID: 20856249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
    Shimizu E; Hashimoto K; Okamura N; Koike K; Komatsu N; Kumakiri C; Nakazato M; Watanabe H; Shinoda N; Okada S; Iyo M
    Biol Psychiatry; 2003 Jul; 54(1):70-5. PubMed ID: 12842310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
    Tsai SJ
    Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
    Aydemir O; Deveci A; Taneli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ratio of mature BDNF to precursor-BDNF in patients with major depressive disorder with severe anhedonia.
    Wu C; Lu J; Lu S; Huang M; Xu Y
    J Psychiatr Res; 2020 Jul; 126():92-97. PubMed ID: 32428748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.
    Munno D; Sterpone S; Fania S; Cappellin F; Mengozzi G; Saroldi M; Bechon E; Zullo G
    Panminerva Med; 2013 Dec; 55(4):377-84. PubMed ID: 24434345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered levels of brain-derived neurotrophic factor, proBDNF and tissue plasminogen activator in children with posttraumatic stress disorder.
    Aksu S; Unlu G; Kardesler AC; Cakaloz B; Aybek H
    Psychiatry Res; 2018 Oct; 268():478-483. PubMed ID: 30142554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
    Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
    J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.